REPOSITORY ID,REPOSITORY LINK,SAMPLE NUMBER,STUDY TITLE,STUDY LINK,ASSAY TYPE,TECHNOLOGY,COUNTRY,DISEASE,DOID,STUDY DESIGN,BODY SITE,PLATFORM,PARTICIPANT FEATURES,AVERAGE SPOTLENGTH,RUN ID,Sample ID,Sample Name,COLLECTION DATE,LIBRARY LAYOUT,LAT LON,SAMPLE TYPE,ETHNICITY,ELO,URBANZATION,REGION,CITYVILLAGE,TARGET AMPLICON,DIET
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428379,SRS3406667,Sample_1123-9,06/26/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428380,SRS3406662,Sample_1125-1,09/19/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428381,SRS3406798,Sample_1456-4,02/20/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428382,SRS3406846,Sample_1872-1,02/06/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428383,SRS3406887,Sample_0903-9,06/26/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428393,SRS3406780,Sample_2604-9,01/12/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428394,SRS3406843,Sample_1742-1,01/10/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428403,SRS3406721,Sample_0494-1,06/13/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428405,SRS3406679,Sample_0333-4,08/13/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428406,SRS3406748,Sample_0532-4,10/11/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,247.0,SRR7428409,SRS3406749,Sample_0532-1,07/09/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428410,SRS3406804,Sample_1981-4,05/16/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428411,SRS3406767,Sample_1361-9,07/24/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428413,SRS3406924,Sample_2251-4,07/24/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428415,SRS3406802,Sample_1872-9,08/13/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428416,SRS3406698,Sample_1143-4,01/30/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428417,SRS3406703,Sample_1143-1,10/11/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428419,SRS3406670,Sample_1125-4,01/16/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428422,SRS3406701,Sample_1192-1,10/03/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428423,SRS3406702,Sample_1143-9,07/10/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428424,SRS3406807,Sample_1974-4,05/16/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428426,SRS3406769,Sample_1271-4,02/13/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,246.0,SRR7428428,SRS3406925,Sample_2251-9,12/18/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428430,SRS3406881,Sample_2595-4,07/25/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,247.0,SRR7428431,SRS3406750,Sample_0494-4,09/24/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293301,SRS3406942,Sample_1101-9,06/12/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293304,SRS3406939,Sample_0982-1,09/10/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,572.0,SRR7293306,SRS3406936,Sample_0990-1,09/12/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,556.0,SRR7293307,SRS3406937,Sample_0982-2,10/10/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293308,SRS3406935,Sample_1101-4,01/09/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,589.0,SRR7293309,SRS3406933,Sample_1101-1,10/03/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,598.0,SRR7293310,SRS3406934,Sample_6002,02/09/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,590.0,SRR7293311,SRS3406932,Sample_6004,02/09/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293312,SRS3406931,Sample_6000,06/11/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293313,SRS3406930,Sample_6001,02/09/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293314,SRS3406929,Sample_2325-2,05/30/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,573.0,SRR7293315,SRS3406927,Sample_2446-1,03/20/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293316,SRS3406928,Sample_6005,02/09/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293317,SRS3406926,Sample_6006,02/10/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293318,SRS3406924,Sample_2251-4,07/24/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293319,SRS3406925,Sample_2251-9,12/18/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,581.0,SRR7293320,SRS3406923,Sample_2282-1,03/20/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293321,SRS3406922,Sample_2325-1,04/29/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,589.0,SRR7293322,SRS3406921,Sample_2105-1,02/06/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,579.0,SRR7293323,SRS3406920,Sample_2105-2,03/06/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,576.0,SRR7293324,SRS3406919,Sample_2105-3,04/06/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,547.0,SRR7293328,SRS3406915,Sample_6043,03/04/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,580.0,SRR7293329,SRS3406914,Sample_6044,03/04/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,544.0,SRR7293331,SRS3406911,Sample_6035,02/27/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,582.0,SRR7293332,SRS3406912,Sample_6036,03/03/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293334,SRS3406910,Sample_8034,04/01/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,581.0,SRR7293335,SRS3406908,Sample_6045,03/09/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293337,SRS3406905,Sample_6008,02/10/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293339,SRS3406904,Sample_0030-1,04/15/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,575.0,SRR7293340,SRS3406961,Sample_8048,04/10/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,579.0,SRR7293342,SRS3406902,Sample_8049,04/25/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,426.0,SRR7293345,SRS3406899,Sample_8062,05/20/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,572.0,SRR7293346,SRS3406898,Sample_8059,05/15/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293348,SRS3406896,Sample_0903-15,01/13/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,589.0,SRR7293351,SRS3406893,Sample_0903-4,12/20/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,539.0,SRR7293352,SRS3406892,Sample_0852-1,08/27/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,591.0,SRR7293354,SRS3406890,Sample_0903-1,09/10/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,589.0,SRR7293355,SRS3406889,Sample_0903-12,09/26/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,531.0,SRR7293356,SRS3406888,Sample_0903-6,03/27/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,589.0,SRR7293358,SRS3406885,Sample_5042-6,03/19/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,589.0,SRR7293361,SRS3406882,Sample_5199-1,10/23/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,536.0,SRR7293362,SRS3406883,Sample_8047,04/10/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,573.0,SRR7293365,SRS3406879,Sample_2483-1,04/04/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293371,SRS3406873,Sample_5263-3,02/19/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293374,SRS3406870,Sample_8018,03/11/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293376,SRS3406868,Sample_5042-2,11/07/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293380,SRS3406865,Sample_5261-1,11/20/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293381,SRS3406863,Sample_5042-1,10/09/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,584.0,SRR7293385,SRS3406858,Sample_0633-9,03/06/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,591.0,SRR7293386,SRS3406857,Sample_0633-6,12/05/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293387,SRS3406856,Sample_0633-4,10/31/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293389,SRS3406854,Sample_0765-1,07/25/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,584.0,SRR7293392,SRS3406850,Sample_0827-1,08/27/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293393,SRS3406851,Sample_0822-1,08/20/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293394,SRS3406852,Sample_5042-4,01/13/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,582.0,SRR7293395,SRS3406849,Sample_1872-12,01/13/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,586.0,SRR7293397,SRS3406847,Sample_1742-4,04/17/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,553.0,SRR7293398,SRS3406846,Sample_1872-1,02/06/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,591.0,SRR7293401,SRS3406843,Sample_1742-1,01/10/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293402,SRS3406842,Sample_1742-15,04/02/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293403,SRS3406841,Sample_5056-3,01/21/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293405,SRS3406839,Sample_1872-4,05/16/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293409,SRS3406835,Sample_6013,02/11/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,589.0,SRR7293412,SRS3406832,Sample_6017,02/13/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,598.0,SRR7293414,SRS3406830,Sample_6021,02/18/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293418,SRS3406825,Sample_8025,03/25/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293419,SRS3406824,Sample_8026,03/25/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293420,SRS3406822,Sample_1361-4,02/20/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,590.0,SRR7293423,SRS3406820,Sample_0633-3,09/26/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293424,SRS3406819,Sample_0633-1,07/23/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293427,SRS3406816,Sample_0632-1,07/18/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,592.0,SRR7293430,SRS3406813,Sample_0588-1,07/11/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293432,SRS3406811,Sample_5042-3,12/10/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293433,SRS3406810,Sample_5297-4,03/12/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293434,SRS3406809,Sample_5300-1,11/20/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293436,SRS3406806,Sample_6057,03/12/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293438,SRS3406805,Sample_1974-1,02/14/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293440,SRS3406803,Sample_1981-1,02/14/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,592.0,SRR7293441,SRS3406802,Sample_1872-9,08/13/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,588.0,SRR7293443,SRS3406801,Sample_1955-4,04/17/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,527.0,SRR7293444,SRS3406799,Sample_1902-1,01/17/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293445,SRS3406798,Sample_1456-4,02/20/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,589.0,SRR7293448,SRS3406795,Sample_5056-1,11/07/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,581.0,SRR7293449,SRS3406794,Sample_5056-2,12/11/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,584.0,SRR7293450,SRS3406793,Sample_8023,03/19/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293454,SRS3406789,Sample_0584-1,07/18/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,598.0,SRR7293455,SRS3406788,Sample_6010,02/11/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,591.0,SRR7293456,SRS3406787,Sample_0575-1,11/07/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,575.0,SRR7293458,SRS3406785,Sample_0575-3,09/24/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,584.0,SRR7293459,SRS3406784,Sample_0575-2,08/20/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293461,SRS3406783,Sample_0563-18,01/21/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293462,SRS3406860,Sample_0564-2,07/30/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,589.0,SRR7293464,SRS3406780,Sample_2604-9,01/12/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293465,SRS3406779,Sample_5198-1,11/06/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293467,SRS3406777,Sample_5098-1,10/23/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293469,SRS3406775,Sample_5263-2,01/13/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293474,SRS3406770,Sample_4973-1,10/09/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293476,SRS3406768,Sample_1361-6,04/24/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293477,SRS3406767,Sample_1361-9,07/24/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,574.0,SRR7293479,SRS3406765,Sample_1411-1,11/28/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,592.0,SRR7293482,SRS3406762,Sample_1460-3,01/23/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,592.0,SRR7293484,SRS3406760,Sample_1539-15,02/26/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,576.0,SRR7293486,SRS3406759,Sample_8035,04/02/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293488,SRS3406756,Sample_1271-9,07/17/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,590.0,SRR7293490,SRS3406754,Sample_1303-3,01/16/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,592.0,SRR7293493,SRS3406751,Sample_4940-2,11/07/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,552.0,SRR7293494,SRS3406750,Sample_0494-4,09/24/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,587.0,SRR7293495,SRS3406749,Sample_0532-1,07/09/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293496,SRS3406747,Sample_0532-2,08/13/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,585.0,SRR7293498,SRS3406746,Sample_0532-6,12/12/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,591.0,SRR7293499,SRS3406828,Sample_0534-1,07/09/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293500,SRS3406745,Sample_0534-9,03/14/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,588.0,SRR7293501,SRS3406744,Sample_0537-1,07/09/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,589.0,SRR7293504,SRS3406739,Sample_1726-1,01/09/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293506,SRS3406742,Sample_1634-2,01/30/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,584.0,SRR7293509,SRS3406736,Sample_1625-1,12/12/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,443.0,SRR7293511,SRS3406734,Sample_1546-1,12/05/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,590.0,SRR7293513,SRS3406732,Sample_6061,03/12/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,587.0,SRR7293515,SRS3406730,Sample_8027,03/25/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,589.0,SRR7293517,SRS3406728,Sample_6054,03/11/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,584.0,SRR7293519,SRS3406726,Sample_6056,03/11/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293521,SRS3406724,Sample_6047,03/05/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,580.0,SRR7293522,SRS3406723,Sample_6052,03/09/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293524,SRS3406721,Sample_0494-1,06/13/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293528,SRS3406717,Sample_0456-1,06/28/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,591.0,SRR7293545,SRS3406700,Sample_1143-3,12/19/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,567.0,SRR7293550,SRS3406695,Sample_8009,03/19/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293551,SRS3406694,Sample_8006,03/18/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293552,SRS3406693,Sample_8007,03/18/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,588.0,SRR7293558,SRS3406686,Sample_6064,03/18/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,592.0,SRR7293563,SRS3406681,Sample_0412-1,06/04/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,590.0,SRR7293564,SRS3406680,Sample_0416-1,06/04/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293566,SRS3406678,Sample_0333-9,01/23/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293567,SRS3406677,Sample_5058-1,10/17/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293568,SRS3406676,Sample_5056-4,02/19/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,592.0,SRR7293569,SRS3406675,Sample_0422-1,06/04/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,288.0,SRR7293571,SRS3406673,Sample_8061,05/20/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,577.0,SRR7293572,SRS3406672,Sample_1361-2,11/28/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293575,SRS3406669,Sample_1125-6,03/27/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,598.0,SRR7293584,SRS3406660,Sample_8016,03/11/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,575.0,SRR7293586,SRS3406658,Sample_6033,02/26/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,569.0,SRR7293587,SRS3406657,Sample_6031,02/26/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293588,SRS3406656,Sample_6026,02/20/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293589,SRS3406655,Sample_6025,02/19/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293590,SRS3406690,Sample_6024,02/19/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,576.0,SRR7293592,SRS3406653,Sample_6030,02/24/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,577.0,SRR7293593,SRS3406652,Sample_6029,02/24/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293595,SRS3406650,Sample_6027,02/23/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,575.0,SRR7293597,SRS3406959,Sample_0044-2,05/23/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293598,SRS3406944,Sample_8045,04/01/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,558.0,SRR7293599,SRS3406957,Sample_0162-1,05/08/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,581.0,SRR7293601,SRS3406955,Sample_0177-1,05/09/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,591.0,SRR7293603,SRS3406953,Sample_0254-9,01/30/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293604,SRS3406952,Sample_0254-6,10/31/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,590.0,SRR7293605,SRS3406949,Sample_0333-1,05/23/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428384,SRS3406933,Sample_1101-1,10/03/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428385,SRS3406890,Sample_0903-1,09/10/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428386,SRS3406893,Sample_0903-4,12/20/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428387,SRS3406943,Sample_1123-1,10/03/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428388,SRS3406668,Sample_1123-4,01/24/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428389,SRS3406935,Sample_1101-4,01/09/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428390,SRS3406942,Sample_1101-9,06/12/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428391,SRS3406735,Sample_1546-4,03/06/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428392,SRS3406884,Sample_2604-4,08/07/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428395,SRS3406734,Sample_1546-1,12/05/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428396,SRS3406755,Sample_1361-1,10/25/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428397,SRS3406856,Sample_0633-4,10/31/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428398,SRS3406822,Sample_1361-4,02/20/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428399,SRS3406874,Sample_2604-1,04/23/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428400,SRS3406839,Sample_1872-4,05/16/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428401,SRS3406858,Sample_0633-9,03/06/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,247.0,SRR7428402,SRS3406678,Sample_0333-9,01/23/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428404,SRS3406949,Sample_0333-1,05/23/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,246.0,SRR7428407,SRS3406819,Sample_0633-1,07/23/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,246.0,SRR7428408,SRS3406764,Sample_1456-1,11/22/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428412,SRS3406803,Sample_1981-1,02/14/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428414,SRS3406918,Sample_2251-1,03/20/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428418,SRS3406704,Sample_1125-9,07/03/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428420,SRS3406763,Sample_1271-1,11/08/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428421,SRS3406773,Sample_1192-4,01/24/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428425,SRS3406756,Sample_1271-9,07/17/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,247.0,SRR7428427,SRS3406880,Sample_2595-1,04/24/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428429,SRS3406805,Sample_1974-1,02/14/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,WGS,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Hiseq 2500,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,250.0,SRR7428432,SRS3406847,Sample_1742-4,04/17/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293299,SRS3406945,Sample_8043,04/01/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293300,SRS3406943,Sample_1123-1,10/03/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293302,SRS3406941,Sample_0943-1,09/12/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,459.0,SRR7293303,SRS3406940,Sample_0921-1,09/12/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,525.0,SRR7293305,SRS3406938,Sample_0969-1,09/12/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293325,SRS3406918,Sample_2251-1,03/20/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,585.0,SRR7293326,SRS3406917,Sample_6040,03/03/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,532.0,SRR7293327,SRS3406916,Sample_6042,03/04/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,578.0,SRR7293330,SRS3406913,Sample_6034,02/27/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,590.0,SRR7293333,SRS3406909,Sample_6038,03/03/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,586.0,SRR7293336,SRS3406906,Sample_6046,03/09/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,577.0,SRR7293338,SRS3406907,Sample_0028-1,04/17/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293341,SRS3406903,Sample_8056,05/07/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,570.0,SRR7293343,SRS3406901,Sample_8053,04/25/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293344,SRS3406900,Sample_8042,03/26/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,558.0,SRR7293347,SRS3406897,Sample_8060,05/15/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293349,SRS3406895,Sample_0903-2,10/11/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293350,SRS3406894,Sample_0903-3,11/15/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,591.0,SRR7293353,SRS3406891,Sample_0871-1,08/27/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,592.0,SRR7293357,SRS3406887,Sample_0903-9,06/26/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293359,SRS3406886,Sample_2604-6,10/09/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293360,SRS3406884,Sample_2604-4,08/07/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,559.0,SRR7293363,SRS3406881,Sample_2595-4,07/25/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,587.0,SRR7293364,SRS3406880,Sample_2595-1,04/24/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,589.0,SRR7293366,SRS3406878,Sample_2471-1,04/10/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,581.0,SRR7293367,SRS3406877,Sample_2604-3,07/03/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293368,SRS3406876,Sample_2604-2,05/29/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293369,SRS3406875,Sample_2604-12,04/09/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293370,SRS3406874,Sample_2604-1,04/23/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293372,SRS3406871,Sample_8020,03/18/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,591.0,SRR7293373,SRS3406872,Sample_8019,03/18/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293375,SRS3406869,Sample_8017,03/11/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293377,SRS3406867,Sample_8014,03/05/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,579.0,SRR7293378,SRS3406866,Sample_8013,03/05/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293379,SRS3406864,Sample_8011,03/19/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,553.0,SRR7293382,SRS3406862,Sample_8022,03/19/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,588.0,SRR7293383,SRS3406861,Sample_8021,03/19/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,589.0,SRR7293384,SRS3406859,Sample_0635-1,07/23/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293388,SRS3406855,Sample_0765-2,08/29/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,567.0,SRR7293390,SRS3406853,Sample_0691-1,07/25/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293391,SRS3406960,Sample_0672-1,07/25/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,578.0,SRR7293396,SRS3406848,Sample_1872-2,03/06/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,582.0,SRR7293399,SRS3406845,Sample_1742-2,02/13/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293400,SRS3406844,Sample_1742-3,03/13/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,589.0,SRR7293404,SRS3406840,Sample_1872-3,04/10/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293406,SRS3406837,Sample_6014,02/12/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293407,SRS3406838,Sample_6016,02/13/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293408,SRS3406836,Sample_6012,02/11/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293410,SRS3406833,Sample_6019,02/17/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293411,SRS3406834,Sample_6020,02/18/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,598.0,SRR7293413,SRS3406831,Sample_6018,02/13/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293415,SRS3406829,Sample_6022,02/18/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293416,SRS3406827,Sample_4940-4,01/21/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,559.0,SRR7293417,SRS3406826,Sample_8024,03/25/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293421,SRS3406823,Sample_8028,03/25/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293422,SRS3406821,Sample_0633-18,12/10/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293425,SRS3406818,Sample_0633-12,06/05/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,591.0,SRR7293426,SRS3406817,Sample_0622-1,07/18/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293428,SRS3406815,Sample_0610-1,07/18/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,556.0,SRR7293429,SRS3406814,Sample_0615-1,07/16/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,592.0,SRR7293431,SRS3406812,Sample_0599-1,07/16/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293435,SRS3406808,Sample_6007,02/10/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293437,SRS3406807,Sample_1974-4,05/16/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293439,SRS3406804,Sample_1981-4,05/16/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,588.0,SRR7293442,SRS3406800,Sample_1872-6,05/16/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,583.0,SRR7293446,SRS3406797,Sample_2033-1,02/14/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,589.0,SRR7293447,SRS3406796,Sample_2027-1,02/14/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293451,SRS3406792,Sample_6009,02/11/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,590.0,SRR7293452,SRS3406791,Sample_4940-3,12/10/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,551.0,SRR7293453,SRS3406790,Sample_0584-2,08/15/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,582.0,SRR7293457,SRS3406786,Sample_0573-1,07/09/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293460,SRS3406782,Sample_0563-9,03/21/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,579.0,SRR7293463,SRS3406781,Sample_0564-1,06/27/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293466,SRS3406778,Sample_5150-1,10/31/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,584.0,SRR7293468,SRS3406776,Sample_1246-1,10/31/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293470,SRS3406774,Sample_4940-1,10/03/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293471,SRS3406772,Sample_5254-1,11/20/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293472,SRS3406773,Sample_1192-4,01/24/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,588.0,SRR7293473,SRS3406771,Sample_5297-1,11/27/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,588.0,SRR7293475,SRS3406769,Sample_1271-4,02/13/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293478,SRS3406766,Sample_1398-1,11/22/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,498.0,SRR7293480,SRS3406764,Sample_1456-1,11/22/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293481,SRS3406763,Sample_1271-1,11/08/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,591.0,SRR7293483,SRS3406761,Sample_1539-1,12/05/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293485,SRS3406758,Sample_1285-1,11/07/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293487,SRS3406757,Sample_4940-6,03/19/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,590.0,SRR7293489,SRS3406755,Sample_1361-1,10/25/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293491,SRS3406753,Sample_0541-1,07/09/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293492,SRS3406752,Sample_0563-12,06/27/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,592.0,SRR7293497,SRS3406748,Sample_0532-4,10/11/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293502,SRS3406743,Sample_1730-1,01/09/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293503,SRS3406740,Sample_1726-3,04/03/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293505,SRS3406738,Sample_1634-3,02/27/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,581.0,SRR7293507,SRS3406741,Sample_1634-1,11/29/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293508,SRS3406737,Sample_1625-2,01/24/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293510,SRS3406735,Sample_1546-4,03/06/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293512,SRS3406733,Sample_5297-3,02/12/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,584.0,SRR7293514,SRS3406731,Sample_6058,03/12/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,583.0,SRR7293516,SRS3406729,Sample_6055,03/11/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293518,SRS3406727,Sample_4973-2,11/06/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,563.0,SRR7293520,SRS3406725,Sample_6048,03/05/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293523,SRS3406722,Sample_6049,03/05/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293525,SRS3406720,Sample_0487-1,06/27/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,588.0,SRR7293526,SRS3406719,Sample_0486-1,06/28/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,581.0,SRR7293527,SRS3406718,Sample_0457-1,06/28/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,575.0,SRR7293529,SRS3406715,Sample_0454-1,06/18/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,585.0,SRR7293530,SRS3406716,Sample_0446-1,06/18/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293531,SRS3406714,Sample_0426-1,06/11/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,569.0,SRR7293532,SRS3406713,Sample_4973-3,12/11/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,591.0,SRR7293533,SRS3406712,Sample_4973-4,01/21/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293534,SRS3406711,Sample_0494-2,07/16/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293535,SRS3406710,Sample_0494-12,05/29/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293536,SRS3406709,Sample_1192-2,11/07/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,554.0,SRR7293537,SRS3406707,Sample_1192-3,12/13/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293538,SRS3406708,Sample_8031,03/26/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,592.0,SRR7293539,SRS3406706,Sample_1143-12,10/09/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,591.0,SRR7293540,SRS3406705,Sample_1143-2,11/15/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293541,SRS3406704,Sample_1125-9,07/03/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,568.0,SRR7293542,SRS3406703,Sample_1143-1,10/11/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,587.0,SRR7293543,SRS3406702,Sample_1143-9,07/10/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293544,SRS3406701,Sample_1192-1,10/03/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,581.0,SRR7293546,SRS3406698,Sample_1143-4,01/30/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293547,SRS3406699,Sample_8029,03/26/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,496.0,SRR7293548,SRS3406697,Sample_8055,05/07/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293549,SRS3406696,Sample_8008,03/18/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,590.0,SRR7293553,SRS3406692,Sample_8003,03/05/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,595.0,SRR7293554,SRS3406691,Sample_8004,03/11/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,580.0,SRR7293555,SRS3406689,Sample_8000,03/05/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,592.0,SRR7293556,SRS3406688,Sample_8001,03/05/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,544.0,SRR7293557,SRS3406687,Sample_6062,03/17/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,561.0,SRR7293559,SRS3406685,Sample_0333-2,06/27/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,579.0,SRR7293560,SRS3406684,Sample_0333-3,07/30/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293561,SRS3406683,Sample_0333-12,04/24/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,591.0,SRR7293562,SRS3406682,Sample_0333-18,10/23/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,593.0,SRR7293565,SRS3406679,Sample_0333-4,08/13/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293570,SRS3406674,Sample_0425-1,06/11/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293573,SRS3406671,Sample_1361-15,02/05/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,571.0,SRR7293574,SRS3406670,Sample_1125-4,01/16/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,591.0,SRR7293576,SRS3406668,Sample_1123-4,01/24/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293577,SRS3406667,Sample_1123-9,06/26/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,597.0,SRR7293578,SRS3406666,Sample_1123-2,11/07/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,546.0,SRR7293579,SRS3406665,Sample_1123-3,12/13/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,590.0,SRR7293580,SRS3406664,Sample_1125-15,01/13/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293581,SRS3406663,Sample_1125-2,10/25/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,591.0,SRR7293582,SRS3406662,Sample_1125-1,09/19/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293583,SRS3406661,Sample_1125-12,10/09/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,542.0,SRR7293585,SRS3406659,Sample_8032,04/01/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,598.0,SRR7293591,SRS3406654,Sample_6023,02/18/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,579.0,SRR7293594,SRS3406651,Sample_6028,02/26/2015,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,518.0,SRR7293596,SRS3406958,Sample_0044-3,06/27/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293600,SRS3406956,Sample_0046-1,04/18/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,596.0,SRR7293602,SRS3406954,Sample_0167-1,05/08/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,565.0,SRR7293606,SRS3406951,Sample_0318-1,05/23/2013,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,592.0,SRR7293607,SRS3406950,Sample_8039,03/25/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,521.0,SRR7293608,SRS3406948,Sample_8036,04/04/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,594.0,SRR7293609,SRS3406947,Sample_8033,04/01/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
PRJNA450025,PRJNA450025,366.0,Evolution of the gut microbiome following acute HIV-1 infection,31078141,Amplicon,Illumina,Mozambique,HIV,526,Case-control,Gut,Illumina Miseq,Participants aged  between 20 and 46 years old anf sometimes treated with standard antiretroviral therapy,591.0,SRR7293610,SRS3406946,Sample_8041,03/26/2014,Paired,"-25.969248, 32.573174",Stool,,,,Manhiça,Maputo,v3-v4,
